Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases

NCT04887298 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma,Soft Tissue
Pulmonary Metastasis

Interventions

DRUG: Liposomal Annamycin (L-Annamycin)

Sponsor

Moleculin Biotech, Inc.